Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications
Abstract
Nitrogen-containing heterocycles (N-Hets) are among the most prevalent and versatile structural motifs in pharmaceuticals, serving as key scaffolds in over 85% of biologically active small molecules. Their structural diversity and functional versatility have made them integral components of both U.S. Food and Drug Administration (FDA) approved and investigational drug molecules, modulating biological activity across a range of molecular targets. In 2025, the FDA approved 26 small-molecule drugs featuring N-Het frameworks, spanning multiple therapeutic areas, including oncology, metabolic disorders, infectious diseases, and rare/orphan conditions. This review offers a comprehensive overview of these newly approved compounds, emphasizing their biological activity and synthetic approaches. Special attention is given to drug-target interactions, focusing on receptor binding and highlighting the important role of N-Hets in medicinal chemistry. By exploiting the intrinsic chemical properties of N-Hets and leveraging modern synthetic methodologies, these scaffolds continue to drive the discovery of therapeutically relevant molecules, highlighting their sustained significance in modern drug discovery.
Read the paper
Related studies
- Noninvasive and Point-of-Care Surface-Enhanced Raman Scattering (SERS)-Based Breathalyzer for Mass Screening of Coronavirus Disease 2019 (COVID-19) under 5 min
- De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus)
- Molecular Characterization and Expression Profiling of Tomato GRF Transcription Factor Family Genes in Response to Abiotic Stresses and Phytohormones
- Assembly of Tight Junction Strands: Claudin-10b and Claudin-3 Form Homo Tetrameric Building Blocks that Polymerise in a Channel-Independent Manner
- Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease‐associated variants, common sequence variants, and results from newborn screening
- Machine Learning-Based SERS Chemical Space for Two-Way Prediction of Structures and Spectra of Untrained Molecules
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.